Insulin lispro Sanofi

Medicinal product

(Invented) name

Insulin lispro Sanofi

Active substance (s)

Insulinas lispro

Strength

100 V/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10AB04, Insulin lispro

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

2017-07-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled pen	1 ml
Insulinas lispro	100 V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68882	83479	1083479	užpildytas švirkštiklis	3 ml N1		Receptinis	EU/1/17/1203/003	Netiekiama	-	-	No	-	-
68883	83480	1083480	užpildytas švirkštiklis	3 ml N3		Receptinis	EU/1/17/1203/004	Netiekiama	-	-	No	-	-
68884	83481	1083481	užpildytas švirkštiklis	3 ml N5		Receptinis	EU/1/17/1203/005	Netiekiama	-	-	No	-	-
68885	83482	1083482	užpildytas švirkštiklis	3 ml N10		Receptinis	EU/1/17/1203/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-07-19	Registruotas